3

Predicting Dupilumab Treatment Outcome in Patients with Primary diffuse Type 2 Chronic Rhinosinusitis.

Soyka M, Ryser F, Brühlmann C, Schmid-Grendelmeier P, Fehr D, Brüggen MC, Steiner U

Vitiligo-like depigmentation in patients treated with checkpoint inhibitors: Clinical characteristics and predictive proteomic patterns.

Hermann N, Maul LV, Traidl S, Ameri M, Ziadlou R, Kolm-Djamei I, Levesque M, Maul JT, Brüggen MC*